Pharmaceutical & Biopharma startups in Southern California
Drug developers and biopharma platforms, concentrated in San Diego's Torrey Pines corridor and the LA biotech cluster. Searched as "pharmaceutical companies in San Diego / Orange County" more than any other industry phrase in our Search Console data.
Companies
Series A$8.0MPharma and medical-device compliance software plus licensing consulting.
$36.0MDevelops FDA-authorized virtual reality therapeutics, including RelieVRx (formerly EaseVRx), a prescription VR program for chronic lower back pain.
Daré Bioscience (Nasdaq: DARE) is a San Diego-based biopharmaceutical company developing and commercializing therapies for women's reproductive and sexual health, an area of medicine it argues has been chronically underfunded relative to its size.
Aggregates medical records from doctors, clinics, hospitals, labs, and pharmacies into one shared patient workspace.
Series B$50.0MKhartis Therapeutics is a San Diego biotechnology company developing oral small-molecule medicines targeting clinically validated immunology pathways. Its lead program is an oral; selective IGF-1R inh
Series B$37.8MAmplifica is a San Diego clinical-stage biopharmaceutical company developing injectable treatments for hair loss. Rather than slowing loss; its approach works on the signalling molecules that govern t
Series B$335.0MCrystalys Therapeutics is a San Diego clinical-stage biotechnology company developing treatments for gout; a disease it argues remains badly served despite being common. Its lead candidate is in pivot
Series B$207.0MWugen is an off-the-shelf Cell Therapies for Cancer founded by Matthew Cooper; Todd Fehniger; Melissa Berrien-Elliott and John DiPersio.
Series A$32.7MFounded in 2017; Onchilles Pharma is a drug-discovery and development company pioneering first-in-class cytotoxic therapies that selectively kill cancer cells while preserving and activating immune fu
Series A$52.0MArnatar Therapeutics develops RNA medicines from a platform it calls DARGER; which pairs highly active siRNA for silencing a gene with ACT-UP1; an antisense technology that does the opposite and incre
Series A$5.0MEntos Pharmaceuticals develops nucleic acid-based therapies using its proprietary Fusogenix drug delivery system.
Seed$44.0MLomond Therapeutics creates pharmacological platforms that target escape mutations.
Series A$10.0MDyania Health develops a research platform for pharma companies and hospital systems.
Series B$180.0MTerray Therapeutics is a Los Angeles-based biotechnology company that combines ultra-high throughput experimentation; generative AI; biology; medicinal chemistry; automation; and nanotechnology to exp
Series C$312.5MEscient Pharmaceuticals is a GPCR-targeted Drugs founded in 2018.
Series A$99.0MAlterome Therapeutics; Inc. is an oncology Treatments founded in 2021 by Eric Murphy.
$15.7MAbintus Bio; Inc. is a San Diego-based; preclinical stage gene therapy company focused on the discovery and development of a portfolio of product candidates that are designed to directly reprogram imm
A biotechnology company focused on the discovery and development of next-generation therapeutics.
$229.0MShoreline Biosciences; Inc. is a Cell-Based Immunotherapies; founded in 2020. It has raised $229M across 4 funding rounds; most recently a $140M in November 2021; from investors including Janus Capita
$125.9MKumquat Biosciences is a San Diego-based biotechnology company focused on the research and development of oncology medicines.
Series B$140.6MAristea Therapeutics is a small Molecules founded in 2018.
Series C$258.0MOperator of a biotechnology company intended to improve outcomes for people with cancer. The company offers a pipeline against validated oncology targets to deliver radioisotopes that emit alpha parti
$100.0MBioTheryX is a small Molecules founded in 2008.
Series B$40.0MPhanes Therapeutics is a treatments for solid tumors and eye diseases.
Series D$799.0MBiosplice Therapeutics is a clinical-stage biotechnology company developing lorecivivint; an injectable small-molecule CLK/DYRK-family inhibitor for knee osteoarthritis.
Series A$58.0MFortis Therapeutics is a San Diego; CA-based immuno-oncology biotech company
Series D$114.0MNeurelis Inc. is a private specialty pharmaceutical company based in San Diego; California; US; providing treatment options for epilepsy and central nervous system disorders.
$100.0MDTx Pharma; Inc. is a San Diego-based company.
Series B$267.0MVividion Therapeutics is a proprietary Screening founded in 2017.
Series C$80.0MPipeline Therapeutics is a small Molecule for MS founded in 2017.
A biopharmaceutical company developing protein therapeutics
Series A$46.5MOutput is a United Kingdom-based company.
Series E$171.5MNovus Therapeutics is an Irvine; California-based company founded in 2017.
Series A$29.0MLibra Therapeutics is a small Molecules for Neurodegenerative Indications founded in 2019.
Series C$120.0MAmplyx Pharmaceuticals; Inc. is a preclinical stage company focusing on the development of small molecule drugs.
$52.0MGPB Scientific is an automation of Cell Therapy Manufacturing.
Series C$22.0MCold Genesys is a privately-held; immunotherapy based biopharmaceutical company
Series A$120.0MMirum Therapeutics is a San Diego-based company in the pharmaceutical industry.
Series A$33.0MQpex Biopharma is a San Diego-based company founded in 2018.
Neurana Pharmaceuticals is a small Molecule.
Series C$79.0MSynthetic biology company that created novel DNA base pairs and uses them to incorporate novel amino acids into proteins for potential therapeutics in areas of cancer and autoimmune disorders.
Series C$34.5MA company focused on developing products for oncology surgery and therapeutic intervention
Series A$13.6MBioniz is a multi-cytokine inhibitory therapeutics.
$32.0MA biotechnology company developing molecular-based diagnostic; prognostic; and predictive medical tests designed to help healthcare practitioners treat cancer.
$138.6MCerulean Pharma; Inc is a company founded in 2006 by Ram Sasisekharan.
Series D$62.1MCrown Bioscience is a contract research organisation for drug discovery; best known for oncology models and also working in cardiovascular and metabolic disease; with sites across the United States; E
A company developing therapeutics for veterinary medicine
Series E$65.0MA biopharmaceutical company that develops therapeutics to treat depressive disorders
Series A$3.6MA biotechnology company developing cancer therapeutics based on antibodies
A company that develops therapeutics for the treatment of cancer
$4.3MGeneTex is a research Antibodies founded in 1997.
CombiMatrix is an Irvine; California-based healthcare company developing products and service for drug development; genetic analysis and diagnostics.
Femta Pharmaceuticals is a biotechnology company that develops protein therapeutics
Series E$20.0MA company developing biologically active compounds and drug candidates
$260.0MA company developing pharmaceutical and diagnostic products to help physicians personalize patient care
A biopharmaceutical company developing small molecule therapeutics for respiratory and inflammatory disorders
Series D$28.0MGenoptix is a Carlsbad; California-based medical diagnostics company offering next-generation sequencing for oncology founded in 1999 by Tina Nova.
$656.4MDeveloping the next generation of oncology therapies for patients.
$413.0MMirador Therapeutics is focused on discovering and developing precision medicines for immune-mediated inflammatory and fibrotic diseases using its Mirador360™ engine, which harnesses biology, multi-modal data, AI, and advanced analytics.
$400.2MAvidity Biosciences is a company driven by the mission to profoundly improve people's lives by revolutionizing a new class of targeted RNA therapeutics through its Antibody Oligonucleotide Conjugates (AOC™) platform.